These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 22974889)
1. Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? Vitale A; Boccagni P; Kertusha X; Zanus G; D'Amico F; Lodo E; Pastorelli D; Ramirez Morales R; Lombardi G; Senzolo M; Burra P; Cillo U Transplant Proc; 2012 Sep; 44(7):1989-91. PubMed ID: 22974889 [TBL] [Abstract][Full Text] [Related]
2. Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. Weinmann A; Niederle IM; Koch S; Hoppe-Lotichius M; Heise M; Düber C; Schuchmann M; Otto G; Galle PR; Wörns MA Dig Liver Dis; 2012 May; 44(5):432-7. PubMed ID: 22265328 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis. Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation. Gomez-Martin C; Bustamante J; Castroagudin JF; Salcedo M; Garralda E; Testillano M; Herrero I; Matilla A; Sangro B Liver Transpl; 2012 Jan; 18(1):45-52. PubMed ID: 21932373 [TBL] [Abstract][Full Text] [Related]
5. Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Yoon DH; Ryoo BY; Ryu MH; Lee SG; Hwang S; Suh DJ; Lee HC; Kim TW; Ahn CS; Kim KH; Moon DB; Kang YK Jpn J Clin Oncol; 2010 Aug; 40(8):768-73. PubMed ID: 20494947 [TBL] [Abstract][Full Text] [Related]
6. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis. Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684 [TBL] [Abstract][Full Text] [Related]
7. Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature. Zavaglia C; Airoldi A; Mancuso A; Vangeli M; Viganò R; Cordone G; Gentiluomo M; Belli LS Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):180-6. PubMed ID: 23044808 [TBL] [Abstract][Full Text] [Related]
8. Clinical course of sorafenib treatment in patients with hepatocellular carcinoma. Woo HY; Heo J; Yoon KT; Kim GH; Kang DH; Song GA; Cho M Scand J Gastroenterol; 2012 Jul; 47(7):809-19. PubMed ID: 22563643 [TBL] [Abstract][Full Text] [Related]
9. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial. Rimassa L; Santoro A Expert Rev Anticancer Ther; 2009 Jun; 9(6):739-45. PubMed ID: 19496710 [TBL] [Abstract][Full Text] [Related]
10. Treating hepatocellular carcinoma with sorafenib in liver transplant patients: an initial experience. Saidi RF; Shah SA; Rawson AP; Grossman S; Piperdi B; Bozorgzadeh A Transplant Proc; 2010 Dec; 42(10):4582-4. PubMed ID: 21168742 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score. Hollebecque A; Cattan S; Romano O; Sergent G; Mourad A; Louvet A; Dharancy S; Boleslawski E; Truant S; Pruvot FR; Hebbar M; Ernst O; Mathurin P Aliment Pharmacol Ther; 2011 Nov; 34(10):1193-201. PubMed ID: 21958438 [TBL] [Abstract][Full Text] [Related]
12. Sorafenib for the treatment of unresectable hepatocellular carcinoma. Kane RC; Farrell AT; Madabushi R; Booth B; Chattopadhyay S; Sridhara R; Justice R; Pazdur R Oncologist; 2009 Jan; 14(1):95-100. PubMed ID: 19144678 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. Abou-Alfa GK; Schwartz L; Ricci S; Amadori D; Santoro A; Figer A; De Greve J; Douillard JY; Lathia C; Schwartz B; Taylor I; Moscovici M; Saltz LB J Clin Oncol; 2006 Sep; 24(26):4293-300. PubMed ID: 16908937 [TBL] [Abstract][Full Text] [Related]
14. Sunitinib in patients with advanced hepatocellular carcinoma after progression under sorafenib treatment. Wörns MA; Schuchmann M; Düber C; Otto G; Galle PR; Weinmann A Oncology; 2010; 79(1-2):85-92. PubMed ID: 21071995 [TBL] [Abstract][Full Text] [Related]
15. High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Staufer K; Fischer L; Seegers B; Vettorazzi E; Nashan B; Sterneck M Transpl Int; 2012 Nov; 25(11):1158-64. PubMed ID: 22882364 [TBL] [Abstract][Full Text] [Related]
16. Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma. Hsu CH; Shen YC; Lin ZZ; Chen PJ; Shao YY; Ding YH; Hsu C; Cheng AL J Hepatol; 2010 Jul; 53(1):126-31. PubMed ID: 20416968 [TBL] [Abstract][Full Text] [Related]
17. A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors. Song T; Zhang W; Wu Q; Kong D; Ma W Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1233-8. PubMed ID: 21941188 [TBL] [Abstract][Full Text] [Related]
18. Using sorafenib for recurrent hepatocellular carcinoma after liver transplantation--interactions between calcineurin inhibitor: two case reports. Takahara T; Nitta H; Hasegawa Y; Itou N; Takahashi M; Wakabayashi G Transplant Proc; 2011 Sep; 43(7):2800-5. PubMed ID: 21911167 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy. Kim JW; Lee JO; Han SW; Oh DY; Im SA; Kim TY; Bang YJ Am J Clin Oncol; 2011 Apr; 34(2):125-9. PubMed ID: 20308869 [TBL] [Abstract][Full Text] [Related]
20. Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant. Truesdale AE; Caldwell SH; Shah NL; Argo CK; Al-Osaimi AM; Schmitt TM; Northup PG Transpl Int; 2011 Oct; 24(10):991-8. PubMed ID: 21777298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]